Perspective Therapeutics Files 8-K

Ticker: CATX · Form: 8-K · Filed: Apr 20, 2026 · CIK: 0000728387

Sentiment: neutral

Topics: 8-K, regulatory-filing, other-events

Related Tickers: PTX

TL;DR

PTX filed an 8-K, check exhibits for details.

AI Summary

Perspective Therapeutics, Inc. filed an 8-K on April 20, 2026, reporting other events. The filing includes various exhibits, such as financial statements and graphics, but does not detail specific transactions or financial figures within the provided text.

Why It Matters

This 8-K filing indicates that Perspective Therapeutics, Inc. has made a regulatory submission, which could contain important updates for investors regarding company events or financial status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K reporting other events and does not disclose any immediate material risks or significant negative developments.

Key Players & Entities

FAQ

What specific events are detailed in the 8-K filing?

The provided text for the 8-K filing indicates Item 8.01 as 'Other Events' and Item 9.01 as 'Financial Statements and Exhibits', but does not specify the nature of these events or financial details.

When was this 8-K filing accepted by the SEC?

The 8-K filing was accepted by the SEC on 2026-04-20 at 06:05:00.

What is the period of report for this filing?

The period of report for this 8-K filing is 2026-04-18.

What types of documents are included as exhibits in this filing?

The exhibits include an iXBRL 8-K, and various other documents labeled EX-99.1, EX-99.2, EX-99.3, and numerous GRAPHIC files, suggesting financial statements and potentially visual data.

Does the filing mention any specific dollar amounts or financial transactions?

The provided text of the 8-K filing does not mention any specific dollar amounts or financial transactions.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 20, 2026 regarding Perspective Therapeutics, Inc. (CATX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing